Who We Are
We are a global leader in generic and biosimilar medicines, committed to playing a leading role in driving access to medicine worldwide.
What We Do
At Sandoz our work is focused on improving access to medicines, access to medical information and access to medical capacity building.
Search for openings and apply for positions at Sandoz locations worldwide.
Sandoz announces further progress on its biosimilar pipeline, with release of positive results for denosumab integrated Phase I/III clinical trial
Novartis announces intention to separate Sandoz business to create a standalone company by way of a 100% spin-off
Applications for proposed first-of-a-kind multiple sclerosis biosimilar natalizumab accepted by US FDA and EMA
At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine.
We are a pioneer and a global leader in biosimilars with over a decade of experience.